Skip to main content
OpenTrials
Completed

NCT Number: NCT05214430

Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery

For patients with Crohn's diseases undergoing surgery,whether postoperative exclusive enteral nutrition(EEN) could delay the endoscopic relapse needs exploration.The trial will investigate the efficacy of postoperative EEN for maintaining disease remission.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

General Surgery Institute,Jinling Hospital,Nanjing,Jiangsu,China

Nanjing, Jiangsu, 210000, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • CD patients who undergoing bowel resection with anastomosis

Exclusion criteria

  • patients who received stoma creation

Treatment and study plan

3 months exclusive enteral nutrition after surgery

Other

patients underwent intestinal resection and anastomosis in this arm will given over 3 months exclusive enteral nutrition,and free diet after 3 months.

Primary outcomes

  1. postoperative endoscopic recurrence

    Time frame: 1 YEAR

    over i2b of rutgeerts score

Sponsors and collaborators

Lead sponsor

Jinling Hospital, China

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2023
First posted
Jan 28, 2022
Registry last updated
Oct 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.